Johns Hopkins University
Baltimore, Maryland, United States
Purpose
to develop a novel vaccine for TB based on existing BCG vaccines modifi ed to express a gene that is specifi c to latent TB in order to generate a robust immune response to a latent infection.
Division
Global Health
Date
May 2009
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Baltimore, Maryland, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.